Sign In
Buy ATRC
$26.20
+0.340 (+1.31%)
At Close: Jun 03, 2026
Here's What Key Metrics Tell Us About AtriCure (ATRC) Q4 Earnings
08:00pm, Tuesday, 17'th Feb 2026
The headline numbers for AtriCure (ATRC) give insight into how the company performed in the quarter ended December 2025, but it may be worthwhile to compare some of its key metrics to Wall Street esti
AtriCure, Inc. (ATRC) Q4 2025 Earnings Call Transcript
07:24pm, Tuesday, 17'th Feb 2026
AtriCure, Inc. (ATRC) Q4 2025 Earnings Call Transcript
AtriCure (ATRC) Tops Q4 Earnings and Revenue Estimates
06:36pm, Tuesday, 17'th Feb 2026
AtriCure (ATRC) came out with quarterly earnings of $0.06 per share, beating the Zacks Consensus Estimate of a loss of $0.02 per share. This compares to a loss of $0.08 per share a year ago.
AtriCure Reports Fourth Quarter 2025 and Full Year 2025 Financial Results
04:01pm, Tuesday, 17'th Feb 2026
MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-op
AtriCure (NASDAQ:ATRC) Shares Gap Down Following Analyst Downgrade
02:38am, Thursday, 12'th Feb 2026
AtriCure, Inc. (NASDAQ: ATRC - Get Free Report) gapped down before the market opened on Wednesday after JPMorgan Chase and Co. downgraded the stock from an overweight rating to a neutral rating. The s
Will AtriCure (ATRC) Report Negative Earnings Next Week? What You Should Know
11:01am, Tuesday, 10'th Feb 2026
AtriCure (ATRC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
AtriCure to Announce Fourth Quarter and Full Year 2025 Financial Results
08:00am, Tuesday, 27'th Jan 2026
MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-o
4 High-Efficiency Stocks Poised to Deliver Superior Returns
10:36am, Thursday, 22'nd Jan 2026
AtriCure tops a screen of high-efficiency stocks, joined by REV Group, Oceaneering International and Analog Devices after beating industry averages.
HARBOR CAPITAL ADVISORS, INC. Buys 4,925 Shares of AtriCure Inc (ATRC)
01:52pm, Tuesday, 20'th Jan 2026
Summary HARBOR CAPITAL ADVISORS, INC. raised its stake in AtriCure Inc (ATRC) by 17.2%, purchasing 4,925 shares to own 33,564 shares valued at about $1
AtriCure, Inc. (NASDAQ:ATRC) Receives Average Rating of “Moderate Buy” from Brokerages
02:10am, Monday, 19'th Jan 2026
Shares of AtriCure, Inc. (NASDAQ: ATRC - Get Free Report) have received an average recommendation of "Moderate Buy" from the twelve analysts that are currently covering the firm, MarketBeat reports. O
AtriCure, Inc. (ATRC) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
04:16pm, Wednesday, 14'th Jan 2026
AtriCure, Inc. (ATRC) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2025, Provides Financial Outlook for 2026
10:21am, Monday, 12'th Jan 2026
MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-op
AtriCure, Inc. (ATRC) Soars to 52-Week High, Time to Cash Out?
10:15am, Friday, 09'th Jan 2026
AtriCure (ATRC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
AtriCure, Inc. (NASDAQ:ATRC) Receives Average Recommendation of “Moderate Buy” from Brokerages
01:47am, Thursday, 25'th Dec 2025
AtriCure, Inc. (NASDAQ: ATRC - Get Free Report) has been assigned a consensus recommendation of "Moderate Buy" from the eleven ratings firms that are covering the stock, Marketbeat.com reports. One re
AtriCure, Inc. (NASDAQ:ATRC) Given Consensus Recommendation of “Moderate Buy” by Analysts
01:46am, Thursday, 25'th Dec 2025
Shares of AtriCure, Inc. (NASDAQ: ATRC - Get Free Report) have been given an average rating of "Moderate Buy" by the eleven brokerages that are covering the firm, Marketbeat.com reports. One research
